FdaApplication
ANDA 070751
Identifiers
- fda_app_no: ANDA070751
Properties
| Property | Value |
|---|---|
| applicant_name | ABRAXIS PHARMACEUTICAL PRODUCTS |
| application_type | ANDA |
| approval_date | 1986-07-02 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALBUPHINE | NALBUPHINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| NALBUPHINE HYDROCHLORIDE | NALBUPHINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
2 products